Specification: |
With the CAS registry number 8006-64-2,?Turpentine is also named as Gum spirits of turpentine.?The product's categories are?Inorganic & Organic Chemicals; Cosmetic Ingredients & Chemicals. It is?colorless liquid with a characteristic odor,?which is insoluble in water and miscible with absolute alcohol, chloroform, ether, benzene, petroleum ether and other solvents. In addition, this chemical is?slightly toxic and flammable by fire, heat and oxidants. When heating it will produce?irritative fume. So the storage environment should be ventilate, low-temperature and dry. Keep Turpentine separate from?oxidizer and?acid.
Preparation of Turpentine:?It?is produced from various species of pines and balsamiferous woods, and several different methods are applied to obtain the oils leading to different types of turpentine, such as dry-distilled wood turpentine from dry distillation of chopped woods and roots of pine trees.
Uses of Turpentine:?It is mainly used as a solvent and as a source of materials for organic synthesis in?industry.?It is also used as a source of raw materials in the synthesis of fragrant chemical compounds.?What's more, this chemical is also added to many cleaning and sanitary products due to its antiseptic properties and its "clean scent".?As a solvent, turpentine is used for thinning oil-based paints, for producing varnishes, and as a raw material for the chemical industry.
When you are using this chemical, please be cautious about it as the following:
It is not only harmful by inhalation, in contact with skin and if swallowed, but also irritating to eyes and skin.?And it is also toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.?Besides, this chemical may cause lung damage if swallowed.?If you want to contact this product, you must wear suitable protective clothing and gloves.?If swallowed, do not induce vomitting; seek medical advice immediately and show this container or label. Avoid release to the environment.
The following are the toxicity data which has been tested.
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
guinea pig |
LCLo |
inhalation |
16gm/m3/1H (16000mg/m3) |
? |
"Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982Vol. -, Pg. 119, 1982. |
human |
LDLo |
unreported |
1777mg/kg (1777mg/kg) |
? |
Forensic Science International. Vol. 65, Pg. 47, 1994. |
human |
TCLo |
inhalation |
175ppm (175ppm) |
SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION
SENSE ORGANS AND SPECIAL SENSES: CONJUNCTIVE IRRITATION: EYE
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Journal of Industrial Hygiene and Toxicology. Vol. 25, Pg. 282, 1943. |
human |
TCLo |
inhalation |
6gm/m3/3H (6000mg/m3) |
SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE
BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"
BEHAVIORAL: HEADACHE |
Archiv fuer Hygiene. Vol. 83, Pg. 239, 1914. |
infant |
LDLo |
oral |
1748mg/kg (1748mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
GASTROINTESTINAL: NAUSEA OR VOMITING
KIDNEY, URETER, AND BLADDER: OTHER CHANGES |
Archives of Disease in Childhood. Vol. 28, Pg. 475, 1953.
? |
infant |
TDLo |
oral |
874mg/kg (874mg/kg) |
BEHAVIORAL: ANTIPSYCHOTIC |
Archives of Disease in Childhood. Vol. 28, Pg. 475, 1953. |
man |
LDLo |
oral |
2857uL/kg (2.857mL/kg) |
BRAIN AND COVERINGS: OTHER DEGENERATIVE CHANGES
LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
KIDNEY, URETER, AND BLADDER: OTHER CHANGES |
Forensic Science International. Vol. 65, Pg. 47, 1994.
? |
man |
LDLo |
oral |
3mg/kg (3mg/kg) |
BEHAVIORAL: MUSCLE WEAKNESS
GASTROINTESTINAL: OTHER CHANGES |
British Medical Journal. Vol. 2, Pg. 77, 1931. |
man |
LDLo |
unreported |
441mg/kg (441mg/kg) |
? |
"Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970Vol. 2, Pg. 73, 1970. |
man |
TCLo |
inhalation |
449mg/m3/2H (449mg/m3) |
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Occupational and Environmental Medicine. Vol. 53, Pg. 100, 1996.
? |
man |
TDLo |
intravenous |
71uL/kg (0.071mL/kg) |
PERIPHERAL NERVE AND SENSATION: ASSOCIATED CONNECTIVE TISSUE
LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
American Journal of Emergency Medicine. Vol. 4, Pg. 543, 1986.
? |
mouse |
LC50 |
inhalation |
29mg/m3/2H (29mg/m3) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: ATAXIA
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION |
Toxicology and Applied Pharmacology. Vol. 6, Pg. 360, 1964. |
mouse |
LD50 |
intravenous |
1180ug/kg (1.18mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
BEHAVIORAL: ATAXIA |
Toxicology and Applied Pharmacology. Vol. 6, Pg. 360, 1964. |
rabbit |
LDLo |
skin |
5010mg/kg (5010mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
National Technical Information Service. Vol. OTS0545856, |
rat |
LC50 |
inhalation |
12gm/m3/6H (12000mg/m3) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Toxicology and Applied Pharmacology. Vol. 10, Pg. 8, 1967.
? |
rat |
LD50 |
oral |
5760mg/kg (5760mg/kg) |
? |
Pharmazie. Vol. 14, Pg. 435, 1959. |
women |
TDLo |
oral |
560mg/kg (560mg/kg) |
KIDNEY, URETER, AND BLADDER: OTHER CHANGES |
Archives of Disease in Childhood. Vol. 28, Pg. 475, 1953. |
|